Belzutifan Generates Superior PFS, ORR in Pretreated Advanced ccRCC
Treatment with belzutifan produced improvements in progression-free survival and objective response rate vs everolimus in patients with pretreated advanced clear cell renal cell carcinoma.
France General Laurence Albiges Department Of Oncology At Gustave Roussy Karnofsky Performance Scale Gustave Roussy Renal Cell Carcinoma
Source: onclive.com